Ho Chi Minh City Oncology Hospital and Bayer Vietnam have signed a Memorandum of Understanding (MoU) to collaborate on ...

“Colorectal cancer is the most common early-onset GI cancer worldwide, accounting for more than half of the cases, but it is ...

Early-onset gastrointestinal (GI) cancers are rising at alarming rates worldwide and, in the U.S., are increasing faster than any other type of early-onset cancer, including breast cancer, according ...

Early-onset gastrointestinal (GI) cancers are rising at alarming rates worldwide and, in the U.S., are increasing faster than ...

Gastrointestinal cancers, which include colorectal, stomach and pancreatic cancer, are rising dramatically in younger adults.

The composition of the gut microbiome appears to be associated with treatment response in patients with pancreatic cancer, research suggests.

Invikafusp alfa, a dual T-cell agonist targeting subsets of tumor-infiltrating lymphocytes, can elicit responses in patients with heavily pretreated gastrointestinal cancers, according to research ...

The CDK2 inhibitor INCB123667 showed positive efficacy and safety signals in platinum-resistant/refractory ovarian cancer.

The conference, with the theme: “Climate Change and Gastrointestinal Health,” brought together experts in hepatology, oncology, gastroenterology, public health, and allied disciplines to examine ...

Further data could back zanidatamab as advanced treatment for HER2-positive advanced gastroesophageal adenocarcinoma.

Individuals with metastatic cancer, meaning their cancer has spread to other parts of the body, have limited treatment options. With a new potential treatment option, researchers have the opportunity ...